Most gynae PCD companies in India are legitimate. A minority are not, and a larger group are simply careless in ways that cost their partners money. The warning signs are consistent and they show up early — usually in the first two conversations, before you have spent anything. Here is what to watch for.
Table of Contents
ToggleThe single clearest signal. The wholesale drug licence is issued to you, and the legal exposure that comes with it is yours. A company willing to be creative about how you obtained it is telling you exactly how it will behave when your licence is the one under inspection.
A company that says “get the licence first, then we’ll talk territory” is protecting you, not obstructing you. See the documents required.
Related, and just as serious. If the inspection arrives before your licence does, the stock is in your godown and the problem is entirely yours. A supplier who waives this to close an order is optimising for their invoice, not your business.
This matters most in the contraceptive, hormonal and injectable range, where Schedule H and Schedule C/C(1) obligations apply.
If exclusivity is not in the written agreement, naming the district and the products, it does not exist. Screenshots are not contracts. Ask directly which districts are yours in writing, and what stops the company appointing someone else there for the products you have not taken.
The full checklist is in monopoly rights in PCD pharma.
In a standard PCD arrangement the company earns by supplying you stock. Franchise fees, registration charges and non-refundable “security deposits” are not the norm. If a significant payment is demanded before anything is dispatched, ask precisely what it buys and get the answer in writing.
Counter-intuitive, but treat this as a warning. Trade terms in PCD are partner-specific — they vary with range, order pattern and territory. A company publishing a fixed margin table to the open web is either advertising a number it will not honour, or telling every existing partner what everyone else pays.
Serious companies issue the price list on request. Be wary of one that broadcasts it.
A small phrase that reveals a lot. WHO-GMP is a compliance standard, not a certification a company holds. The accurate claim is that products are manufactured at WHO-GMP compliant units. A company that writes “certified” is either careless with regulatory language or hoping you will not know the difference — and neither is reassuring in a business built on regulatory discipline.
Apply the same test to “our manufacturing plant”. Many gynae PCD companies are marketing and distribution businesses that do not own plants. There is nothing wrong with that model — Halefem operates it — but a company blurring the line is choosing to.
A company with a real partner map can tell you in minutes whether your district is open. One that repeatedly says “we’ll check and come back” may be deciding whether you are worth more than the incumbent. Ask who they currently supply within 100 km of you. The reaction tells you more than the answer.
You need these for your own stock records and for any query a chemist raises months later. An invoice without them is a company that either cannot produce them or does not think you need them.
A partner starting with one or two series relevant to the doctors they already call on will do better than one who stocks 200 products with no prescriber for most of them. Capital tied up in slow lines expires on your shelf — the biggest single destroyer of realised margin, as covered in profit margins in gynae PCD.
A company that pushes a maximal opening order is optimising its own cash flow against your risk.
Visual-aid folders, product card manuals, MR bags, order books, samples and reminder cards are normally supplied free against your order as per demand. It is the company’s own marketing. Charging for it is unusual and worth questioning.
Notice period on both sides, what happens to unsold stock, whether the company can sell direct into your territory. An agreement silent on how it ends is not protective — and silence favours whoever has the lawyers.
Ask what the inositol ratio is, whether the progesterone soft-gel is suitable for vaginal use, what the elemental iron content is. If nobody can answer without calling someone back, consider what will happen when a gynaecologist asks you the same question in a consulting room.
Offering to arrange your drug licence, dispatching against a pending licence, monopoly rights not recorded in writing, large upfront fees before any product moves, and publishing fixed margin tables publicly. Any one of these justifies slowing down.
Usually not. In a standard PCD arrangement the company earns from supplying stock. If a significant payment is required before anything is dispatched, ask specifically what it covers and get it in writing.
No. WHO-GMP is a compliance standard rather than a certification a company holds. The accurate phrasing is that products are manufactured at WHO-GMP compliant units. Loose regulatory language is a reasonable warning sign.
Because trade terms in PCD are partner-specific. A public margin table is either a number that will not be honoured or a disclosure of what existing partners pay. Reputable companies issue the list on request.
Batch numbers and expiry dates on every line, alongside the standard tax details. You need these for stock records and for any query raised later by a chemist.
Halefem Gynae markets 200+ gynae formulations across six therapeutic series to franchise partners across India, one partner per district. A valid drug licence and GST registration in your own name are required before we can supply.
Call +91-9888020547 to check whether your district is open, or read about the gynae PCD pharma franchise, documents required, monopoly rights, what it costs to start, and the full gynae product range. Price list on request.
Halefem Gynae — a gynae division of Edmund Healthcare Pvt. Ltd., an ISO 9001:2015 certified company. Products manufactured at WHO-GMP compliant units, Sai Road, Baddi, Himachal Pradesh.
Written for pharmaceutical distributors and healthcare professionals in India. Not medical advice; prescribing decisions rest with the treating clinician.
\n